Lv1
58 积分 2024-11-14 加入
Pharmacogenetic biomarkers for predicting drug response
19小时前
已关闭
Endometrial cancer
2天前
已完结
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
7天前
已完结
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
7天前
已完结
Non-small-cell lung cancer
8天前
已完结
Evaluation of risk factors associated with carboplatin and nab-paclitaxel treatment suspension in patients with non-small cell lung cancer
10天前
已完结
Risk assessment of febrile neutropenia and evaluation of G-CSF use in patients with cancer: a real-life study
11天前
已完结
A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non–Small-Cell Lung Cancer (NSCLC)
13天前
已完结
Is it appropriate to select patients for primary prophylactic use of pegfilgrastim based on the risk of febrile neutropenia?
14天前
已完结
Pegylated filgrastim is comparable with filgrastim as support for commonly used chemotherapy regimens
14天前
已完结
皖公网安备34019202002308
